{"schema_version":"secwatch.filing_event.v1","accession":"0001093557-25-000264","form_type":"8-K","ticker":"DXCM","cik":"0001093557","company_name":"DEXCOM INC","filed_at":"2025-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.773395+00:00","generated_at":"2026-05-17T02:08:33.766640+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Dexcom appoints Dr. Euan Ashley to board; board size expanded to 11 in 2026","bullets":["Appointed Euan Ashley, M.D., to Board effective Oct 24, 2025; board size increased to 10 then to 11 effective Jan 1, 2026.","Ashley chairs Stanford Dept. of Medicine, co-founded 7 biotech firms, brings clinical and AI/digital health expertise.","Received initial RSU grant of $500k vesting over 3 years; eligible for annual director equity grant of $345k.","Appointed to Nominating and Governance Committee and Technology Committee; Kyle Malady steps down from Nominating but remains Tech chair."],"urls":{"canonical":"https://secwatch.observer/filing/0001093557-25-000264","json":"https://secwatch.observer/filing/0001093557-25-000264.json","markdown":"https://secwatch.observer/filing/0001093557-25-000264.md","text":"https://secwatch.observer/filing/0001093557-25-000264.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000264/0001093557-25-000264-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000264/dxcm-20251024.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:08:33.766640+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}